Mifepristone and misoprostol versus Dilapan and sulprostone for second trimester termination of pregnancy

被引:10
作者
Jansen, Nicoline E. [1 ]
Pasker-De Jong, Pieternel C. M. [2 ]
Zondervan, Hans A. [3 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynecol, NL-6500 HB Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands
[3] Rijnstate Hosp, Dept Obstet & Gynecol, Arnhem, Netherlands
关键词
Mifepristone; misoprostol; second trimester; sulprostone; termination of pregnancy;
D O I
10.1080/14767050802283027
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective. To compare two methods for second trimester termination of pregnancy: mifepristone and misoprostol versus Dilapan and sulprostone. Methods. This was a randomized study involving 16 patients with a singleton live fetus with congenital malformations or genetic disorders. Eight patients were treated with 200mg mifepristone orally followed by 200g misoprostol vaginally 3 hourly and eight patients received a sulprostone infusion after cervical dilatation with Dilapan. Results. Mifepristone and misoprostol had a mean induction interval of 17.8 hours and sulprostone and Dilapan 20.9 hours. The mean induction interval did not differ significantly. Mean hospital stay was shorter in the patients treated with misoprostol: 2.1 vs. 3.3 days (p=0.02) with a 95% confidence interval of -2.1 to 0.3. Conclusion. Mifepristone and misoprostol did not reduce the induction interval significantly compared to the sulprostone and Dilapan treatment for second trimester pregnancy termination. Hospital admission was significantly shorter in patients treated with mifepristone and misoprostol.
引用
收藏
页码:847 / 851
页数:5
相关论文
共 10 条
  • [1] Rupture in an unscarred uterus during second trimester pregnancy termination with mifepristone and misoprostol
    Bagga, R
    Chaudhary, N
    Kalra, J
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2004, 87 (01) : 42 - 43
  • [2] BEERENDONK CC, 1998, NED TIJDSCHR GENEES, V142, P192
  • [3] Low dose sulprostone for termination of second and third trimester pregnancies
    de Boer, MA
    van Gemund, N
    Scherjon, SA
    Kanhai, HHH
    [J]. EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2001, 99 (02): : 244 - 248
  • [4] Medical management for termination of second and third trimester pregnancies: a comparison of strategies
    de Heus, R
    Graziosi, GCM
    Christiaens, GCML
    Bruinse, HW
    Mol, BWJ
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2004, 116 (01) : 16 - 21
  • [5] Drug therapy: Misoprostol and pregnancy.
    Goldberg, AB
    Greenberg, MB
    Darney, PD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (01) : 38 - 47
  • [6] Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy
    Ho, PC
    Ngai, SW
    Liu, KL
    Wong, GCY
    Lee, SWH
    [J]. OBSTETRICS AND GYNECOLOGY, 1997, 90 (05) : 735 - 738
  • [7] TERMINATION OF 2ND TRIMESTER PREGNANCY WITH LAMINARIA AND INTRAMUSCULAR 16-PHENOXY-OMEGA-17,18,19,20 TETRANOR PGE2 METHYLSULFONYLAMIDE (SULPROSTONE) - A RANDOMIZED STUDY
    KARIM, SMM
    RATNAM, SS
    LIM, AL
    YEO, KC
    CHOO, HT
    [J]. PROSTAGLANDINS, 1982, 23 (02): : 257 - 263
  • [8] Second and third medical termination of pregnancy with misoprostol without mifepristone
    Langer, B
    Peter, C
    Firtion, C
    David, E
    Haberstich, R
    [J]. FETAL DIAGNOSIS AND THERAPY, 2004, 19 (03) : 266 - 270
  • [9] Stoutjesdijk J A, 2004, Ned Tijdschr Geneeskd, V148, P1293
  • [10] Medical abortion in the second trimester
    Tang, OS
    Ho, PC
    [J]. BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY, 2002, 16 (02): : 237 - 246